Lymphomatoid papulosis and progression to T cell lymphoma: An immunophenotypic and genotypic analysis

1989 ◽  
Vol 21 (5) ◽  
pp. 951-957 ◽  
Author(s):  
Douglas S. Harrington ◽  
Suzanne W. Braddock ◽  
Kathleen S. Blocher ◽  
Dennis D. Weisenburger ◽  
Warren Sanger ◽  
...  
1992 ◽  
Vol 326 (17) ◽  
pp. 1115-1122 ◽  
Author(s):  
Thomas H. Davis ◽  
Cynthia C. Morton ◽  
Robert Miller-Cassman ◽  
Steven P. Balk ◽  
Marshall E. Kadin

2019 ◽  
Vol 5 (3) ◽  
pp. 264-266
Author(s):  
Emilie Doré Badje ◽  
Trilok Tejasvi ◽  
Alexandra Hristov

2019 ◽  
Vol 152 (Supplement_1) ◽  
pp. S113-S114
Author(s):  
Ismail Elbaz Younes ◽  
Julia Rewerska ◽  
Victoria Alagiozian-Angelova

Abstract Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma is a rare entity accounting for <1% of all cutaneous T-cell lymphomas. Almost all patients present with generalized skin lesions. This type of lymphoma has an extremely aggressive course with a median survival of 12 months. It tends to spread to other visceral sites, but lymph nodes are usually spared. We describe a case of a 59-year-old male with multiple necrotic malodours ulcers for several months. The first lesion was on his left thigh, followed by another lesion on his right chest and right eyelid. Medical history revealed newly diagnosed diabetes mellitus. The patient received antibiotics, presumptively for infectious etiology of the skin lesion, with no improvement. The right thigh lesion was excised and histomorphologic examination revealed a deep dermal proliferation of large-sized pleomorphic cells with marked pagetoid epidermotropism and skin ulceration. The adnexal skin structures were invaded by the lesion. The lesional cells were immunoreactive for CD3, CD7, CD8, and granzyme B; they were negative for CD4, CD5, CD56, and CD30. The immunophenotype confirms the entity that we have at hand in addition to the similar clinical picture that the patient presented with. This disease usually shows clonal TR gene rearrangements; nonetheless, no specific mutational aberration has been described. Our patient received chemotherapy; however, new lesions continued to erupt and he opted to proceed with palliative care. Clinical information is needed to give this diagnosis as it may look identical to a variant of lymphomatoid papulosis (type D), CD8-positive cutaneous T-cell lymphoma. We present this case due to the importance of clinical pathologic coloration to prevent misdiagnosis with mimickers as the ones pointed out earlier, and it is a provisional rare entity in the 2018 WHO classification of Tumors of Haematopoietic and Lymphoid Tissues.


1983 ◽  
Vol 9 (5) ◽  
pp. 743-747 ◽  
Author(s):  
James F. Madison ◽  
Thomas E. O’Keefe ◽  
Frederick A. Meier ◽  
William E. Clendenning

Cancer ◽  
1992 ◽  
Vol 70 (4) ◽  
pp. 835-839 ◽  
Author(s):  
Yasuaki Harabuchi ◽  
Akikatsu Kataura ◽  
Kazutoyo Kobayashi ◽  
Tetsuo Yamamoto ◽  
Noboru Yamanaka ◽  
...  

Blood ◽  
2019 ◽  
Vol 133 (16) ◽  
pp. 1703-1714 ◽  
Author(s):  
Rein Willemze ◽  
Lorenzo Cerroni ◽  
Werner Kempf ◽  
Emilio Berti ◽  
Fabio Facchetti ◽  
...  

Abstract Primary cutaneous lymphomas are a heterogeneous group of T- and B-cell lymphomas that present in the skin with no evidence of extracutaneous disease at the time of diagnosis. The 2005 World Health Organization–European Organization for Research and Treatment of Cancer (WHO-EORTC) consensus classification has served as a golden standard for the diagnosis and classification of these conditions. In September 2018, an updated version of the WHO-EORTC was published in the fourth edition of the WHO Classification of Skin Tumours Blue Book. In this classification, primary cutaneous acral CD8+ T-cell lymphoma and Epstein-Barr virus positive (EBV+) mucocutaneous ulcer are included as new provisional entities, and a new section on cutaneous forms of chronic active EBV disease has been added. The term “primary cutaneous CD4+ small/medium T-cell lymphoma” was modified to “primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder” because of its indolent clinical behavior and uncertain malignant potential. Modifications have also been made in the sections on lymphomatoid papulosis, increasing the spectrum of histologic and genetic types, and primary cutaneous marginal zone lymphomas recognizing 2 different subtypes. Herein, the characteristic features of these new and modified entities as well as the results of recent molecular studies with diagnostic, prognostic, and/or therapeutic significance for the different types of primary cutaneous lymphomas are reviewed. An update of the frequency and survival of the different types of primary cutaneous lymphomas is provided.


1986 ◽  
Vol 15 (3) ◽  
pp. 444-458 ◽  
Author(s):  
Gary S. Wood ◽  
John G. Strickler ◽  
David G. Deneau ◽  
Barbara Egbert ◽  
Roger A. Warnke

Sign in / Sign up

Export Citation Format

Share Document